SG Americas Securities
TBRA

SG Americas Securities’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

SG Americas Securities’s Portfolio TBRA Stock Details TBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-66,271
Closed -$2.63M – 3721
2016
Q3 		$2.63M Buy
+66,271
New +$739K 0.03% 594
2015
Q2 		– Sell
-1,802
Closed -$20K – 2989
2015
Q1 		$20K Buy
1,802
+370
+26% +$3.97K ﹤0.01% 2438
2014
Q4 		$12K Sell
1,432
-3,130
-69% -$26.9K ﹤0.01% 3089
2014
Q3 		$46K Buy
+4,562
New +$90.1K ﹤0.01% 2498

SG Americas Securities's TBRA Position: Q4 2016 in Review

SG Americas Securities sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 66,271 shares — an estimated $2.63M sold.

SG Americas Securities first reported a position in TBRA in Q3 2014 and held it in 4 quarters. The position peaked at $2.63M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

  • SG Americas Securities reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • SG Americas Securities sold 66,271 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $2.63M.
  • SG Americas Securities first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2014 and held it in 4 quarters.
  • SG Americas Securities's Tobira Therapeutics, Inc. Common Stock position peaked at $2.63M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on SG Americas Securities's 13F filing for Q4 2016, filed 8 Feb 2017.